Functional characterization of a novel somatic oncogenic mutation of PIK3CB

Yazar: Whale, Andrew D, Colman, Lucy, Lensun, Letitia, Rogers, Helen L, Shuttleworth, Stephen J
Yayımlandı Signal Transduct Target Ther (2017)

Exploring the specificity of the PI3K family inhibitor LY294002

Yazar: Gharbi, Severine I., Zvelebil, Marketa J., Shuttleworth, Stephen J., Hancox, Tim, Saghir, Nahid, Timms, John F., Waterfield, Michael D.
Baskı/Yayın Bilgisi 2007

Compensation between CSF1R(+) macrophages and Foxp3(+) Treg cells drives resistance to tumor immunotherapy

Yazar: Gyori, David, Lim, Ee Lyn, Grant, Francis M., Spensberger, Dominik, Roychoudhuri, Rahul, Shuttleworth, Stephen J., Okkenhaug, Klaus, Stephens, Len R., Hawkins, Phillip T.
Yayımlandı JCI Insight (2018)

Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941

Yazar: Raynaud, Florence I., Eccles, Suzanne A., Patel, Sonal, Alix, Sonia, Box, Gary, Chuckowree, Irina, Folkes, Adrian, Gowan, Sharon, De Haven Brandon, Alexis, Di Stefano, Francesca, Hayes, Angela, Henley, Alan T., Lensun, Letitia, Pergl-Wilson, Giles, Robson, Anthony, Saghir, Nahid, Zhyvoloup, Alexander, McDonald, Edward, Sheldrake, Peter, Shuttleworth, Stephen, Valenti, Melanie, Wan, Nan Chi, Clarke, Paul A., Workman, Paul
Baskı/Yayın Bilgisi 2009